Skip to main content
. 2019 Feb 19;14:100335. doi: 10.1016/j.conctc.2019.100335

Table 2.

Number of eligible participants recruited to trial, and those not randomised due to treatment preference.

Conventional RCTs (n = 42)
Author Number of eligible participants consenting to randomisation arms Number of eligible patients not randomised because of treatment preference n (%) Is preference expressed by patients (in addition to parents)
Allen 2013 1 (10%) (Feasibility) 7 (70%) Yes (only patient preference reported)
Allmark 2010 325 (81%) Unclear, preference reported qualitatively [45]
‘30 declined’ ‘45 other reasons’ [90]
n/a neonates
Banks 2012 76 (50%) (Pilot) 6 (4%) No
Barratt 2013 258 (33%) Not reported.
9 (26%) of non-responders reported concern with being in either the intervention or control group, but only 37/305 non-responders replied to question.
No
Bauchner 1996 648 (total eligible not reported) Not reported.
Parents were asked their preference at enrollment and 551 (85%) of those randomised preferred single-dose therapy over standard therapy.
n/a children under 6yrs
Blickman 2013 142 (88%) 4 (2%) Unclear (patients aged 4yrs + were asked to complete a standardised study instrument)
Byrne-Davis 2010 521 (71%) [103] Not reported, preference reported qualitatively [47]
215 (29%) not randomly assigned; 97 refused, 7 had Down's syndrome, 4 because of toxic effects, 28 other reason, 79 unknown [103]
No
Caldwell 2003 Not reported (multiple trials) Not reported, preference reported qualitatively. Participant age not stated.
Carvalho 2013 Unclear 48 'recruited' [82] 44 (100%) 'randomised' [99] Not reported, preference reported qualitatively [82]
3 (7%) parents refused allocated interventions post-randomisation in x 2 trial arms [99]
No
Chappuy 2014 Not reported Not reported.
Some Parents felt that standard treatment was the best arm for their child because it was less risky
Participant age not stated.
Duncan 2004 50 different participants randomised. Total eligible not reported. 8 (between 12 and 16%) No
Eiser
2005
1621 (90%) [98] 181 (10%) declined randomisation
(opted for PRED; 165 DEXA; 16) [98]
Preference reported qualitatively, 16 (32%) ‘agreed reluctantly to randomisation’ [49].
No
Forsander 1995 38 (93%) Not reported
Immediately after randomisation 3 families in the control arm reported that they would have preferred the family therapeutic care arm.
No
Glogowska 2001 159 (69%) [94] Not reported, preference reported qualitatively [50]
Declined trial in total 70 (31%) [94]
n/a children under 4yrs
Harth 1990 72 (55%) 40 (30%) families declined because of ‘concern about side effects of the new drug’ (ketotifen) 60 declined in total. n/a children under 3yrs
Hissink Muller 2011 Not reported Not reported.
41% participating parents reported a preference for therapy with methotrexate and etanercept and 6% had hoped against assignment to this group. Primary aversion was highest (25%) in the prednisone group [40]. Declined trial n = 38 (29%) [96].
No
Hissink Muller 2012 Not reported Not reported.
65% participating parents reported a preference for therapy with etanercept. 5 parents and 2 patients participated in the study to access treatment with etanercept, as initial treatment was not possible nor reimbursed in daily practice.
Yes
Johnson 2007 Not reported Not reported.
Participating families stated: Close monitoring arm - 27% parents and 70% participants were glad to be in that arm. 74% parents and 35% participants sometimes wished they had been assigned the intervention arm. Intervention arm - 53% parents and 21% participants were glad to be in that arm. 25% parents and 47% participants sometimes wished they had been assigned the closely monitored arm.
Yes
Johnson 2009 Not reported Not reported.
Participating families were blinded to treatment but were asked which treatment arm they would have preferred. 60% parents and 53% participants chose the capsule condition. 8% parents and 21% participants chose the no intervention condition. Very few participants and parents (3%) chose the insulin injection condition.
Yes
Jollye 2009 Not reported, multiple trials. Not reported, preference reported qualitatively. n/a neonates
Levi 2000 Not reported, multiple trials. Unclear.
3 (13.6%) stated they declined participation because they felt more comfortable with a “tried and true” method.
No
Miner 2007 41 (82%) Unclear.
Declined randomised 9 (18%) reasons not reported. After allocation 4 (10%) parents requested that their child receive nebulized fentanyl rather than the assigned IV fentanyl.
No
Payne 2004 Unclear
Calculated as; 322 (69%) of eligible patients. Paper reports recruitment rate of 75%
59 (50%) ‘Around half of the eligible participants who refused to participate did so because there was a 50% chance of the child being randomised to the inhalational induction arm’. No
(PENTA) Paediatric European Network for Treatment of AIDS 1999 197 4 (3%) parents stated explicitly that they were concerned with the use of placebo. No
Rovers 2000 187 Not reported.
19 (10%) parents withdrew consent straight after randomisation (15 in ventilation tubes arm and 4 in watchful waiting arm). 10 (5%) children in the watchful waiting arm were treated with ventilation tubes.
n/a children under 2yrs
Sammons 2007 Unclear
245 'randomised’ [55]
252 (85%) ‘randomised’ [89]
25 (9%) declining families stated they wanted a specific treatment (IV; 20 or oral; 5) [55]
43 (15%) declined to take part; n = 6 (2%) excluded post randomisation reasons: 4 withdrawn by parents/2 by clinician (no further detail provided) [89].
No
Sandler 2014 78 (87%) 7 (8%) Three did not want to wear headgear for anchorage, three did not want the Nance button palatal arches, but only one patient did not want to take part because he or she was unhappy at “the thought of temporary anchorage devices”. No
Sartain 2002 399 (86%) 10 (2%)
7 families withdrew from ‘hospital care’ arm because they wanted the ‘hospital at home’ arm
Yes
Schuttelaar 2010 160 4 (2%) Preferred only dermatologist (n = 2), preferred only nurse practitioner (n = 2). No
Sederberg-olsen 1998 429 120 (10%) parents insisted that the child had grommet insertion performed at the time of randomisation. No
Shilling 2011 MASCOT:
63 [97]
MENDS:
146 (84%) [88]
POP: [still recruiting]
TIPIT:
153 (57%) [108]
Unclear, preference reported qualitatively.
MASCOT Assessed for eligibility (n = 898), Not registered (n = 732), Excluded (n = 103) [97].
MMENDS 27 (16%) assessed for eligibility but not randomised: ‘declined 11’ ‘other 16’ [88].
TIPIT 57 (21%) assessed for eligibility but not randomised: ‘refused’ [105].
Yes
Snowdon 1997 185 (79%) [95] Unclear.
‘majority of parents had a keen preference for ECMO treatment arm’. Preference reported qualitatively [58].
48 (21%) were registered but not randomised; 14 died, 19 improved and 15 parents refused trial participation [95].
n/a neonates
Spandorfer 2005 73 24 (7%)
A further 3 parents refused participation after randomisation to oral rehydration therapy before starting treatment.
n/a children under 3yrs
Sureshkumar 2012 412 (37%) [85] 214 (19%) Prefer antibiotics 71/Prefer no antibiotics 143 [85].
Primary paper reports patients excluded because ‘participation refused by parent’ 1935 [92]
No
Tercyak 1998 56 2 (5%) Yes (only patient preference reported)
Willey 2005 31 Not reported.
19/31 patients completed a preference questionnaire/10 (43%) preference for oral, 2 (9%) for suppositories, 7 (30%) no preference/preference for oral more pronounced among girls 5 (83%).
Yes
Williams 2013 94 Not reported.
A significantly larger percentage of parents and patients in the cast group reported that they would not choose the same method of immobilization again at all time points (baseline, days; 1, 3, 7, 21 after injury).
No
Woodgate 2010 Not reported (multiple trials) Not reported, preference reported qualitatively. n/a neonates
Woolfall 2013 MASCOT:
63 [97]
MENDS:
146 (84%) [88]
POP: [still recruiting]
TIPIT:
153 (57%) [108]
Unclear, preference reported qualitatively.
MASCOT Assessed for eligibility (n = 898), Not registered (n = 732), Excluded (n = 103) [97].
MMENDS 27 (16%) assessed for eligibility but not randomised: ‘declined 11’ ‘other 16’ [88].
TIPIT 57 (21%) assessed for eligibility but not randomised; ‘refused’ [105].
No
Wright 2005 108 (46%) 41 (33%) No
Wynn 2010 234 (29%) 2% unwilling to take placebo. n/a children under 2yrs
Young 2006 Not reported. 125
‘Reluctance toward medication treatment accounted for 44.7% of study refusals and was disproportionately common among ethnic minority families’.
No
RCTs with non-randomised preference arms (n = 10)
Cunningham 2011 Not reported. (multiple trials) Not reported.
A small number of patients who were eligible declined the trial as they had a treatment preference. These were patients allocated to both intervention groups, so one treatment option was not preferred to the other. Preference arms added.
Unclear
Gowers 2010 170 (68%) 28 (11%)
Not randomised, patient preference.
Yes
Lock 2010 268 (26%) 286 (28%) declined any follow up, authors assumed that all had a patient preference.
461 (45%) opted for preference arms in cohort.
Only in qualitative sample. Authors did not attempt to differentiate between parent/child preferences in RCT/preference samples.
Mattila 2007 137 (45%) 169 (55%) opted for preference arms. n/a children under 2yrs
Paradise 1984 91 (49%) 96 (51%) opted for preference arms. No
Paradise 1990 99 (46%) 114 (54%) opted for preference arms. No
Reddihough 1998 34 (49%) 32 (46%) declined randomisation. n/a children under 3yrs
Rovers
2001
187 (48%) 133 (34%) opted for non-randomised cohort arms.
66 (17%) refused randomisation/follow up via cohort.
n/a children under 1yrs
Van Wijk 2014 84 (21%) 186 (46%) opted for preference arms. n/a children under 1yrs
Weinstein 2013 155 (14%) 228 (21%) opted for preference arms.
297 (27%) declined all follow-up due to preference.
216 (20%) no to randomisation.
No